Osteoblast Role in Rheumatic Diseases
AbstractAlterations in osteoblast growth, differentiation and activity play a role in the pathogenesis of several rheumatic diseases, such as rheumatoid arthritis, spondyloarthritides, osteoarthritis, and osteoporosis. In fact, in these rheumatic diseases, abnormal activity of Wnt signaling, receptor activator of nuclear factor-κB (RANK)-RANK ligand (RANKL)-osteoprotegerin (OPG) signaling, bone morphogenetic proteins (BMPs) pathway and other mechanisms have been described in osteoblasts. This review article is focused on current knowledge on the role of osteoblast dysregulation occurring in rheumatic diseases. View Full-Text
Share & Cite This Article
Corrado, A.; Maruotti, N.; Cantatore, F.P. Osteoblast Role in Rheumatic Diseases. Int. J. Mol. Sci. 2017, 18, 1272.
Corrado A, Maruotti N, Cantatore FP. Osteoblast Role in Rheumatic Diseases. International Journal of Molecular Sciences. 2017; 18(6):1272.Chicago/Turabian Style
Corrado, Addolorata; Maruotti, Nicola; Cantatore, Francesco P. 2017. "Osteoblast Role in Rheumatic Diseases." Int. J. Mol. Sci. 18, no. 6: 1272.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.